Secukinumab for Giant Cell Arteritis.

Stone JH, Venhoff N, Buttgereit F, Dejaco C, Schmidt WA, Spiera R, Blanco R, Rubbert-Roth A, Von Frenckell C, Blockmans D, Terrier B, Tracey G, Hauge EM, Keyport MP, Ng J, Hiremath R, Fu R, Cho G, Bacher G, Thiel J, Mendelson MH

Open source

DOI
10.1056/evidoa2600112
Published
2026 Jul
Container
NEJM evidence
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1056/evidoa2600112,
  title = {Secukinumab for Giant Cell Arteritis.},
  author = {Stone JH and Venhoff N and Buttgereit F and Dejaco C and Schmidt WA and Spiera R and Blanco R and Rubbert-Roth A and Von Frenckell C and Blockmans D and Terrier B and Tracey G and Hauge EM and Keyport MP and Ng J and Hiremath R and Fu R and Cho G and Bacher G and Thiel J and Mendelson MH},
  year = {2026},
  journal = {NEJM evidence},
  doi = {10.1056/evidoa2600112},
  url = {https://doi.org/10.1056/evidoa2600112}
}

RIS

TY  - JOUR
TI  - Secukinumab for Giant Cell Arteritis.
AU  - Stone JH
AU  - Venhoff N
AU  - Buttgereit F
AU  - Dejaco C
AU  - Schmidt WA
AU  - Spiera R
AU  - Blanco R
AU  - Rubbert-Roth A
AU  - Von Frenckell C
AU  - Blockmans D
AU  - Terrier B
AU  - Tracey G
AU  - Hauge EM
AU  - Keyport MP
AU  - Ng J
AU  - Hiremath R
AU  - Fu R
AU  - Cho G
AU  - Bacher G
AU  - Thiel J
AU  - Mendelson MH
PY  - 2026
JO  - NEJM evidence
DO  - 10.1056/evidoa2600112
UR  - https://doi.org/10.1056/evidoa2600112
ER  - 

APA

JH, S., N, V., F, B., C, D., WA, S., R, S., R, B., A, R., C, V. F., D, B., B, T., G, T., EM, H., MP, K., J, N., R, H., R, F., G, C., G, B., J, T., & MH, M. (2026). Secukinumab for Giant Cell Arteritis.. NEJM evidence. https://doi.org/10.1056/evidoa2600112

Source records